Status:
COMPLETED
Detrol LA In Men With Overactive Bladder.
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Overactive Bladder (OAB)
Eligibility:
MALE
40+ years
Phase:
PHASE4
Brief Summary
An interventional active/placebo double blinded parallel randomized controlled study in which at 12 weeks of treatment, the primary endpoint of patient perception of bladder condition is measured alon...
Eligibility Criteria
Inclusion
- Symptoms of OAB (frequency more than 8 per day and Urgency more than 1 episode per day confirmed by bladder diary)
Exclusion
- Significant hepatic or renal disease, history of radiation treatment
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
End Date :
May 14 2007
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00282932
Start Date
January 1 2006
End Date
May 14 2007
Last Update
January 27 2021
Active Locations (81)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Anaheim, California, United States, 92801
2
Pfizer Investigational Site
La Mesa, California, United States, 91942
3
Pfizer Investigational Site
Aurora, Colorado, United States, 80012
4
Pfizer Investigational Site
Iowa City, Iowa, United States, 52242-1089